Evaluation of the Long-Term Tolerability and Clinical Benefit of Vorinostat in Patients With Advanced Cutaneous T-Cell Lymphoma
Clinical Lymphoma and Myeloma · 2009-12 · 9 (6) · 412-416
DOI: 10.3816/clm.2009.n.082 ↗Kurz gefasst
Klinische Studie (Phase II) in der Zeitschrift Clinical Lymphoma and Myeloma, 2009-12. Verfasst von Madeleine Duvic und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, The University of Texas M. D. Anderson Cancer Center, Box 1492, 1515 Holcombe Blvd, Houston, TX 77030, USA. mduvic@mdander…. Die Arbeit wurde bisher 82-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, The University of Texas M. D. Anderson Cancer Center, Box 1492, 1515 Holcombe Blvd, Houston, TX 77030, USA. mduvic@mdanderson.org
Zitieren
APA
Duvic, M., Olsen, E. A., Breneman, D., Pacheco, T. R., Parker, S., Vonderheid, E. C., Abuav, R., Ricker, J. L., Rizvi, S., Chen, C., Boileau, K., Gunchenko, A., Sanz-Rodriguez, C., & Geskin, L. J. (2009). Evaluation of the Long-Term Tolerability and Clinical Benefit of Vorinostat in Patients With Advanced Cutaneous T-Cell Lymphoma. Clinical Lymphoma and Myeloma, 9(6), 412-416. https://doi.org/10.3816/clm.2009.n.082
Vancouver
Duvic M, Olsen EA, Breneman D, Pacheco TR, Parker S, Vonderheid EC, et al. Evaluation of the Long-Term Tolerability and Clinical Benefit of Vorinostat in Patients With Advanced Cutaneous T-Cell Lymphoma. Clinical Lymphoma and Myeloma. 2009;9(6):412-416. doi:10.3816/clm.2009.n.082
BibTeX
@article{Duvic2009,
author = {Duvic, Madeleine and Olsen, Elise A and Breneman, Debra and Pacheco, Theresa R and Parker, Sareeta and Vonderheid, Eric C and Abuav, Rachel and Ricker, Justin L and Rizvi, Syed and Chen, Cong and Boileau, Kathleen and Gunchenko, Alexandra and Sanz-Rodriguez, Cesar and Geskin, Larisa J},
title = {Evaluation of the Long-Term Tolerability and Clinical Benefit of Vorinostat in Patients With Advanced Cutaneous T-Cell Lymphoma},
journal = {Clinical Lymphoma and Myeloma},
year = {2009},
volume = {9},
number = {6},
pages = {412--416},
doi = {10.3816/clm.2009.n.082}
}
EUVIMED